Key facts
- It has raised $1.9M.
- Notable investors include MassChallenge, Venture Kick, Kickfund, BlueLion Incubator, Gebert Rüf Foundation — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for CellX Biosolutions
- ·The full record, as it builds
Funding rounds
No funding rounds for CellX Biosolutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CellX Biosolutions
Provider of biodegradation optimization services intended to provide sustainable industrial chemical waste treatment. The company's services include the biodiscovery of custom bacterial communities, optimization of these communities for specific chemical waste, biodegradability studies for chemical products, deployment in aqueous environments using microfluidic devices, and bacteria cultivation for enhanced biodegradation, enabling industries to sustainably manage pollutants, pharmaceuticals, and microplastics and chemical and pharmaceutical producers to treat their chemical waste in a cost-efficient and sustainable way.
- Sector
- Business Products and Services (B2B)
- HQ
- Zurich, Switzerland
- Founded
- 2024
- Employees
- 8
- Website
- cellx.ch/
- Ownership
- Privately Held (backing)
CellX Biosolutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CellX Biosolutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CellX Biosolutions in its N-PORT filings yet. We sweep new filings monthly.